TR199902315T2 - Kuinolin-2-karboksilik asit ve uyar�c� amino asit antagonisti olarak kullan�m�. - Google Patents
Kuinolin-2-karboksilik asit ve uyar�c� amino asit antagonisti olarak kullan�m�.Info
- Publication number
- TR199902315T2 TR199902315T2 TR1999/02315T TR9902315T TR199902315T2 TR 199902315 T2 TR199902315 T2 TR 199902315T2 TR 1999/02315 T TR1999/02315 T TR 1999/02315T TR 9902315 T TR9902315 T TR 9902315T TR 199902315 T2 TR199902315 T2 TR 199902315T2
- Authority
- TR
- Turkey
- Prior art keywords
- quinoline
- carboxylic acid
- antagonist
- excitatory amino
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9706294.7A GB9706294D0 (en) | 1997-03-26 | 1997-03-26 | Heterocyclic compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199902315T2 true TR199902315T2 (xx) | 2000-05-22 |
Family
ID=10809909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR1999/02315T TR199902315T2 (xx) | 1997-03-26 | 1998-03-24 | Kuinolin-2-karboksilik asit ve uyar�c� amino asit antagonisti olarak kullan�m�. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0971896A1 (xx) |
| JP (1) | JP2001518901A (xx) |
| KR (1) | KR20010005567A (xx) |
| CN (1) | CN1257482A (xx) |
| AP (1) | AP9901659A0 (xx) |
| AU (1) | AU731394B2 (xx) |
| BR (1) | BR9808424A (xx) |
| CA (1) | CA2284710A1 (xx) |
| EA (1) | EA199900755A1 (xx) |
| GB (1) | GB9706294D0 (xx) |
| HU (1) | HUP0001661A3 (xx) |
| ID (1) | ID24306A (xx) |
| IL (1) | IL131919A0 (xx) |
| IS (1) | IS5186A (xx) |
| NO (1) | NO994679L (xx) |
| NZ (1) | NZ337793A (xx) |
| PL (1) | PL335865A1 (xx) |
| TR (1) | TR199902315T2 (xx) |
| WO (1) | WO1998042673A1 (xx) |
| YU (1) | YU47699A (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9917822D0 (en) * | 1999-07-29 | 1999-09-29 | Imperial College | Nmda antagonist |
| DE10132725A1 (de) | 2001-07-05 | 2006-08-03 | Grünenthal GmbH | Substituierte γ-Lactonverbindungen |
| DE10137487A1 (de) * | 2001-08-03 | 2003-03-27 | Gruenenthal Gmbh | Substituierte 5,6,6a,11b-Tetrahydro-7-oxa-6-aza- benzo[c]fluoren-6-carbonsäurederivate |
| DE10306202A1 (de) | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| JP4360891B2 (ja) | 2003-12-09 | 2009-11-11 | アルパイン株式会社 | 放送受信機能を備えた電子装置およびその装置における電子番組ガイドの表示方法 |
| ES2531621T3 (es) * | 2005-07-22 | 2015-03-18 | Mochida Pharmaceutical Co., Ltd. | Derivado de heterociclidenacetamida novedoso |
| RU2451014C2 (ru) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| CN110996948A (zh) | 2017-06-12 | 2020-04-10 | 格莱泰施有限责任公司 | 用nmda拮抗剂和d2/5ht2a或选择性5ht2a拮抗剂治疗抑郁症 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL93610A0 (en) * | 1989-03-08 | 1990-12-23 | Merck Sharp & Dohme | Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them |
| AP876A (en) * | 1995-09-29 | 2000-09-27 | Glaxo Wellcome Spa | Tetrahydroquinolines as NMDA antagonists. |
| GB9617305D0 (en) * | 1996-08-17 | 1996-09-25 | Glaxo Wellcome Spa | Heterocyclic compounds |
-
1997
- 1997-03-26 GB GBGB9706294.7A patent/GB9706294D0/en active Pending
-
1998
- 1998-03-24 AP APAP/P/1999/001659A patent/AP9901659A0/en unknown
- 1998-03-24 HU HU0001661A patent/HUP0001661A3/hu unknown
- 1998-03-24 JP JP54323498A patent/JP2001518901A/ja active Pending
- 1998-03-24 CA CA002284710A patent/CA2284710A1/en not_active Abandoned
- 1998-03-24 EP EP98919133A patent/EP0971896A1/en not_active Withdrawn
- 1998-03-24 YU YU47699A patent/YU47699A/sh unknown
- 1998-03-24 ID IDW991108A patent/ID24306A/id unknown
- 1998-03-24 EA EA199900755A patent/EA199900755A1/ru unknown
- 1998-03-24 IL IL13191998A patent/IL131919A0/xx unknown
- 1998-03-24 TR TR1999/02315T patent/TR199902315T2/xx unknown
- 1998-03-24 CN CN98805302A patent/CN1257482A/zh active Pending
- 1998-03-24 WO PCT/EP1998/001700 patent/WO1998042673A1/en not_active Application Discontinuation
- 1998-03-24 NZ NZ337793A patent/NZ337793A/en unknown
- 1998-03-24 KR KR1019997008630A patent/KR20010005567A/ko not_active Application Discontinuation
- 1998-03-24 BR BR9808424-0A patent/BR9808424A/pt not_active IP Right Cessation
- 1998-03-24 AU AU72094/98A patent/AU731394B2/en not_active Ceased
- 1998-03-24 PL PL98335865A patent/PL335865A1/xx unknown
-
1999
- 1999-09-17 IS IS5186A patent/IS5186A/is unknown
- 1999-09-24 NO NO994679A patent/NO994679L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2284710A1 (en) | 1998-10-01 |
| GB9706294D0 (en) | 1997-05-14 |
| AU7209498A (en) | 1998-10-20 |
| NO994679L (no) | 1999-11-24 |
| BR9808424A (pt) | 2000-05-23 |
| KR20010005567A (ko) | 2001-01-15 |
| AP9901659A0 (en) | 1999-09-30 |
| ID24306A (id) | 2000-07-13 |
| EA199900755A1 (ru) | 2000-08-28 |
| NZ337793A (en) | 2001-02-23 |
| HUP0001661A2 (hu) | 2000-09-28 |
| YU47699A (sh) | 2001-12-26 |
| CN1257482A (zh) | 2000-06-21 |
| IL131919A0 (en) | 2001-03-19 |
| AU731394B2 (en) | 2001-03-29 |
| NO994679D0 (no) | 1999-09-24 |
| WO1998042673A1 (en) | 1998-10-01 |
| HUP0001661A3 (en) | 2001-12-28 |
| JP2001518901A (ja) | 2001-10-16 |
| IS5186A (is) | 1999-09-17 |
| EP0971896A1 (en) | 2000-01-19 |
| PL335865A1 (en) | 2000-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200002015T2 (tr) | Protein tirosin kinaz inhibitörleri olarak bisiklik heteroaromatik bileşikler. | |
| CA2473991A1 (en) | Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor | |
| TR199900049T2 (xx) | Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler. | |
| TR199900048T2 (xx) | Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler | |
| EP0394905A3 (en) | Excitatory amino acid antagonists | |
| BR0308967A (pt) | Derivados de quinolina e isoquinolina, um processo para a sua preparação e sua aplicação como inibidores de inflamação | |
| EP0271287A3 (en) | Quinoline dioic acids and amides | |
| TR199902315T2 (xx) | Kuinolin-2-karboksilik asit ve uyar�c� amino asit antagonisti olarak kullan�m�. | |
| TR199901604T2 (xx) | Tedavide yararl� kinolin ve kinazolin bile�ikleri. | |
| TR199901949T2 (xx) | Lemfositik t�m�rler i�in �areler. | |
| TR199800531T1 (xx) | NMDA antagonistleri olarak tetrahidrokinolinler. | |
| DE69614149D1 (de) | Chinolinderivate als antimalariamittel | |
| TR200103457T2 (tr) | 4-Fenil-Pirimidin Türevleri. | |
| TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
| TR200000697T2 (tr) | İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları. | |
| ATE285772T1 (de) | Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten | |
| ATE414100T1 (de) | Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen | |
| HUP0000882A2 (hu) | NMDA (N-metil-D-aszpartát) antagonista hatású indolszármazékok, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
| TR199901416T2 (xx) | Heterosiklik karbonikasit t�revleri. | |
| TR200000371T2 (tr) | 3-İkame edilen 3,4,5,7,- tetrahidro-pirrolo [3',4':4,5] tieno[2,3-D] pirimidin türevleri, üretimi ve 5HT-antagonistleri olarak kullanımları. | |
| TR199903159T2 (xx) | Yeni �-Amino ve �-Azido karbonik asit t�revleri. | |
| HUP0302136A2 (hu) | Endogén véralvadást aktíváló vegyületek és alkalmazásuk az endogén véralvadás feltárásában | |
| TR200201503T2 (tr) | Heterosiklik türevler. | |
| BR9811954A (pt) | ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias | |
| HUP0202895A2 (hu) | Eljárás késleltetett hatóanyag-leadású komplexek előállítására |